4-isocyanato-4-phenylcyclohexanone, ethylene ketal | 65619-17-2

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 4-isocyanato-4-phenylcyclohexanone, ethylene ketal
• 英文别名: 8-isocyanato-8-phenyl-1,4-dioxaspiro[4.5]decane
• CAS: 65619-17-2
• 化学式: C₁₅H₁₇NO₃
• 分子量: 259.305
• InChiKey: YJZBIZUHEJXCGJ-UHFFFAOYSA-N

物化性质

• 熔点：
  48-50 °C(Solv: ligroine (8032-32-4))
• 沸点：
  384.6±42.0 °C(Predicted)
• 密度：
  1.21±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  19
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.53
• 拓扑面积：
  47.9
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  4-isocyanato-4-phenylcyclohexanone, ethylene ketal 在 sodium tetrahydroborate 、 lithium aluminium tetrahydride 作用下， 以 四氢呋喃 为溶剂， 反应 10.0h， 生成 N,N-dimethyl-8-phenyl-1,4-dioxaspiro[4.5]decan-8-amine
  参考文献：
  名称：

  4-Amino-4-arylcyclohexanones and their derivatives, a novel class of analgesics. 1. Modification of the aryl ring

  摘要：

  Investigation of central nervous system activity of phenylcyclohexylamines was continued by preparation of "reversed" analogues. Following the unexpected finding of analgesic activity with 1-(dimethylamino)-1-phenylcyclohexylamine, the SAR of the series was investigated. Synthesis starts by double Michael reaction of acrylate on arylacetonitriles. Following cyclization, decarboxylation, ketalization, and saponification, the geminally substituted acid is rearranged to the isocyanate by means of (C6H5O)2PON3. Isocyanates were then converted to the title compounds. Analgesic activity is very sensitive to the nature and position of the substitutent on the aromatic ring. The most potent compounds in this series (p-CH3, p-Br) showed 50% the potency of morphine. Deletion of the ring oxygen abolishes activity.

  DOI：

  10.1021/jm00178a014
• 作为产物：
  描述：

  C₁₅H₁₇N₃O₃ 以 苯甲醚 为溶剂， 反应 2.0h， 生成 4-isocyanato-4-phenylcyclohexanone, ethylene ketal
  参考文献：
  名称：

  Spirocyclic Azaindole Derivatives

  摘要：

  该发明涉及取代的氮杂吲哚衍生物，其制备方法，含有该化合物的药物以及使用取代的氮杂吲哚衍生物来生产药物。

  公开号：

  US20090156593A1

文献信息

• SUBSTITUTED HETEROARYL DERIVATIVES
  申请人：Zemolka Saskia

  公开号：US20100009986A1

  公开（公告）日：2010-01-14

  The invention relates to substituted heteroaryl derivatives, to methods for the production thereof, to medicaments containing said compounds and to the use of substituted heteroaryl derivatives for producing medicaments.

  这项发明涉及替代杂环芳基衍生物，涉及其生产方法，含有该化合物的药物以及利用替代杂环芳基衍生物生产药物的用途。
• 4-Amino-4-aryl-cyclohexanones
  申请人：The Upjohn Company

  公开号：US04460604A1

  公开（公告）日：1984-07-17

  A class of 4-amine-4-arylcyclohexanones, their ketals, and acid addition salts have been synthesized and found to be useful for relieving pain in animals. Their analgesic activity appears to be of high order, and in addition some exhibit narcotic antagonist activity that is useful in modifying the cardiovascular, respiratory, and behavioral depression caused by other analgesics. Several show mixed analgesic and narcotic antagonist activity. Preferred compounds of the class are 4-(m-hydroxyphenyl)-4-dimethylaminocyclohexanone ethylene ketal, and 4-(m-hydroxyphenyl)-4-(n-butylmethylamino)cyclohexanone ethylene ketal as free bases and as their hydrochloride salts. Processes for synthesis and intermediates are described. Unit dosage forms and therapeutic treatments are disclosed.

  一类4-氨基-4-芳基环己酮及其缩酮和酸加成盐已经被合成，并发现它们对动物缓解疼痛非常有用。它们的镇痛活性似乎是很高的，此外，一些化合物还表现出镇痛拮抗活性，对于调节其他镇痛药物引起的心血管、呼吸和行为抑制非常有用。几种化合物显示出混合的镇痛和镇痛拮抗活性。该类化合物中的优选化合物是4-(间羟基苯基)-4-二甲氨基环己酮乙烯缩酮和4-(间羟基苯基)-4-(正丁基甲基氨基)环己酮乙烯缩酮，作为自由碱和它们的盐酸盐。描述了合成和中间体的过程。公制剂量形式和治疗方法也被披露。
• Substituted heteroaryl derivatives
  申请人：Gruenenthal GmbH

  公开号：US08138187B2

  公开（公告）日：2012-03-20

  The invention relates to substituted heteroaryl derivatives, to methods for the production thereof, to medicaments containing said compounds and to the use of substituted heteroaryl derivatives for producing medicaments.

  本发明涉及取代杂环芳基衍生物，其生产方法，含有该化合物的药物以及利用取代杂环芳基衍生物生产药物的用途。
• Spirocyclic azaindole derivatives
  申请人：Zemolka Saskia

  公开号：US08399503B2

  公开（公告）日：2013-03-19

  The invention relates to substituted azaindole derivatives, to methods for the production thereof, to medicaments containing said compounds and to the use of substituted azaindole derivatives for producing medicaments.

  本发明涉及取代的氮杂吲哚衍生物，其制备方法，含有该化合物的药物以及使用取代的氮杂吲哚衍生物制备药物的用途。
• LEDNICER D.; VOIGTLANDER P. F.; EMMERT D. E., J. MED. CHEM., 1980, 23, NO 4, 424-430
  作者：LEDNICER D.、 VOIGTLANDER P. F.、 EMMERT D. E.

  DOI：——

  日期：——